Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort

Wei Li, Shannon L. Risacher, Edgar Huang, Andrew Saykin

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: We investigated type 2 diabetes mellitus (T2DM) as a risk factor for brain atrophy and glucose hypometabolism in older adults with or at risk of cognitive impairment. Methods: Participants with the T2DM were identified from the Alzheimer's Disease Neuroimaging Initiative (ADNI-1/GO/2 cohorts). Analysis of covariance models were used to compare participants with and without T2DM, controlling for potential confounding factors. Results: Whole brain volume and whole brain [ 18 F]-fluorodeoxyglucose (FDG) uptake were significantly different as a function of T2DM status, independent of baseline clinical diagnosis. On post hoc analysis, a lower whole brain volume was seen in participants with both mild cognitive impairment (MCI) and T2DM (n 76) compared with participants who had MCI but not T2DM (n 747; p 0.009). Similarly, mean FDG uptake in gray matter and white matter was lower in participants with both MCI and T2DM (n 72) than in participants with MCI without T2DM (n 719; p 0.04). Subsequent regional analysis revealed that the decreased FDG uptake in participants with both MCI and T2DM was mainly manifested in 3 brain regions: frontal lobe, sensory motor cortex, and striatum. Conclusions: T2DM may accelerate cognition deterioration in patients with MCI by affecting glucose metabolism and brain volume.

Original languageEnglish (US)
Pages (from-to)595-600
Number of pages6
JournalNeurology
Volume87
Issue number6
DOIs
StatePublished - Aug 9 2016

Fingerprint

Type 2 Diabetes Mellitus
Atrophy
Brain
Glucose
Fluorodeoxyglucose F18
Frontal Lobe
Cognitive Dysfunction
Neuroimaging
Cognition
Alzheimer Disease

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Neurology

Cite this

Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. / Li, Wei; Risacher, Shannon L.; Huang, Edgar; Saykin, Andrew.

In: Neurology, Vol. 87, No. 6, 09.08.2016, p. 595-600.

Research output: Contribution to journalArticle

Li, Wei ; Risacher, Shannon L. ; Huang, Edgar ; Saykin, Andrew. / Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. In: Neurology. 2016 ; Vol. 87, No. 6. pp. 595-600.
@article{3f712d86ea5f4d11ae0e3859390866f3,
title = "Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort",
abstract = "Objective: We investigated type 2 diabetes mellitus (T2DM) as a risk factor for brain atrophy and glucose hypometabolism in older adults with or at risk of cognitive impairment. Methods: Participants with the T2DM were identified from the Alzheimer's Disease Neuroimaging Initiative (ADNI-1/GO/2 cohorts). Analysis of covariance models were used to compare participants with and without T2DM, controlling for potential confounding factors. Results: Whole brain volume and whole brain [ 18 F]-fluorodeoxyglucose (FDG) uptake were significantly different as a function of T2DM status, independent of baseline clinical diagnosis. On post hoc analysis, a lower whole brain volume was seen in participants with both mild cognitive impairment (MCI) and T2DM (n 76) compared with participants who had MCI but not T2DM (n 747; p 0.009). Similarly, mean FDG uptake in gray matter and white matter was lower in participants with both MCI and T2DM (n 72) than in participants with MCI without T2DM (n 719; p 0.04). Subsequent regional analysis revealed that the decreased FDG uptake in participants with both MCI and T2DM was mainly manifested in 3 brain regions: frontal lobe, sensory motor cortex, and striatum. Conclusions: T2DM may accelerate cognition deterioration in patients with MCI by affecting glucose metabolism and brain volume.",
author = "Wei Li and Risacher, {Shannon L.} and Edgar Huang and Andrew Saykin",
year = "2016",
month = "8",
day = "9",
doi = "10.1212/WNL.0000000000002950",
language = "English (US)",
volume = "87",
pages = "595--600",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort

AU - Li, Wei

AU - Risacher, Shannon L.

AU - Huang, Edgar

AU - Saykin, Andrew

PY - 2016/8/9

Y1 - 2016/8/9

N2 - Objective: We investigated type 2 diabetes mellitus (T2DM) as a risk factor for brain atrophy and glucose hypometabolism in older adults with or at risk of cognitive impairment. Methods: Participants with the T2DM were identified from the Alzheimer's Disease Neuroimaging Initiative (ADNI-1/GO/2 cohorts). Analysis of covariance models were used to compare participants with and without T2DM, controlling for potential confounding factors. Results: Whole brain volume and whole brain [ 18 F]-fluorodeoxyglucose (FDG) uptake were significantly different as a function of T2DM status, independent of baseline clinical diagnosis. On post hoc analysis, a lower whole brain volume was seen in participants with both mild cognitive impairment (MCI) and T2DM (n 76) compared with participants who had MCI but not T2DM (n 747; p 0.009). Similarly, mean FDG uptake in gray matter and white matter was lower in participants with both MCI and T2DM (n 72) than in participants with MCI without T2DM (n 719; p 0.04). Subsequent regional analysis revealed that the decreased FDG uptake in participants with both MCI and T2DM was mainly manifested in 3 brain regions: frontal lobe, sensory motor cortex, and striatum. Conclusions: T2DM may accelerate cognition deterioration in patients with MCI by affecting glucose metabolism and brain volume.

AB - Objective: We investigated type 2 diabetes mellitus (T2DM) as a risk factor for brain atrophy and glucose hypometabolism in older adults with or at risk of cognitive impairment. Methods: Participants with the T2DM were identified from the Alzheimer's Disease Neuroimaging Initiative (ADNI-1/GO/2 cohorts). Analysis of covariance models were used to compare participants with and without T2DM, controlling for potential confounding factors. Results: Whole brain volume and whole brain [ 18 F]-fluorodeoxyglucose (FDG) uptake were significantly different as a function of T2DM status, independent of baseline clinical diagnosis. On post hoc analysis, a lower whole brain volume was seen in participants with both mild cognitive impairment (MCI) and T2DM (n 76) compared with participants who had MCI but not T2DM (n 747; p 0.009). Similarly, mean FDG uptake in gray matter and white matter was lower in participants with both MCI and T2DM (n 72) than in participants with MCI without T2DM (n 719; p 0.04). Subsequent regional analysis revealed that the decreased FDG uptake in participants with both MCI and T2DM was mainly manifested in 3 brain regions: frontal lobe, sensory motor cortex, and striatum. Conclusions: T2DM may accelerate cognition deterioration in patients with MCI by affecting glucose metabolism and brain volume.

UR - http://www.scopus.com/inward/record.url?scp=84981240792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981240792&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000002950

DO - 10.1212/WNL.0000000000002950

M3 - Article

C2 - 27385744

AN - SCOPUS:84981240792

VL - 87

SP - 595

EP - 600

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -